BRPI1014627A2 - Processo para a preparação de [4-(2-cloro-4-metóxi-5-metilfenil)-5-metil-tiazolo-2-il]-[ 2-ciclopropil-1-(3-flúor-4-metilfenil)-etil]-amina - Google Patents

Processo para a preparação de [4-(2-cloro-4-metóxi-5-metilfenil)-5-metil-tiazolo-2-il]-[ 2-ciclopropil-1-(3-flúor-4-metilfenil)-etil]-amina

Info

Publication number
BRPI1014627A2
BRPI1014627A2 BRPI1014627-0A BRPI1014627A BRPI1014627A2 BR PI1014627 A2 BRPI1014627 A2 BR PI1014627A2 BR PI1014627 A BRPI1014627 A BR PI1014627A BR PI1014627 A2 BRPI1014627 A2 BR PI1014627A2
Authority
BR
Brazil
Prior art keywords
methylphenyl
methylthiazolo
cyclopropyl
fluoro
chloro
Prior art date
Application number
BRPI1014627-0A
Other languages
English (en)
Inventor
Zsolt Parkanyi
János Fazekas
Péter Miskolczi
Annamária Molnár
Béla Ágai
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of BRPI1014627A2 publication Critical patent/BRPI1014627A2/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38Nitrogen atoms
    • C07D277/42Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C331/00Derivatives of thiocyanic acid or of isothiocyanic acid
    • C07C331/02Thiocyanates
    • C07C331/04Thiocyanates having sulfur atoms of thiocyanate groups bound to acyclic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D327/00Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms
    • C07D327/02Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms one oxygen atom and one sulfur atom
    • C07D327/04Five-membered rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D339/00Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms
    • C07D339/02Five-membered rings
    • C07D339/06Five-membered rings having the hetero atoms in positions 1 and 3, e.g. cyclic dithiocarbonates
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F216/00Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by an alcohol, ether, aldehydo, ketonic, acetal or ketal radical
    • C08F216/12Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by an alcohol, ether, aldehydo, ketonic, acetal or ketal radical by an ether radical
    • C08F216/14Monomers containing only one unsaturated aliphatic radical
    • C08F216/1466Monomers containing sulfur
    • C08F216/1483Monomers containing sulfur and nitrogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
BRPI1014627-0A 2009-04-30 2010-04-26 Processo para a preparação de [4-(2-cloro-4-metóxi-5-metilfenil)-5-metil-tiazolo-2-il]-[ 2-ciclopropil-1-(3-flúor-4-metilfenil)-etil]-amina BRPI1014627A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU0900267A HUP0900267A2 (en) 2009-04-30 2009-04-30 Process for preparing of thiazole amines and intermediates thereof
PCT/HU2010/000047 WO2010125414A1 (en) 2009-04-30 2010-04-26 Process for the preparation of [4-(2-chloro-4-methoxy-5-methylphenyl)-5-methyl-thiazolo-2-yl]-[2-cyclopropyl-1-(3-fluoro-4-methylphenyl)-ethyl]-amine

Publications (1)

Publication Number Publication Date
BRPI1014627A2 true BRPI1014627A2 (pt) 2015-08-25

Family

ID=89988941

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI1014627-0A BRPI1014627A2 (pt) 2009-04-30 2010-04-26 Processo para a preparação de [4-(2-cloro-4-metóxi-5-metilfenil)-5-metil-tiazolo-2-il]-[ 2-ciclopropil-1-(3-flúor-4-metilfenil)-etil]-amina

Country Status (19)

Country Link
US (1) US8314249B2 (pt)
EP (1) EP2424848B1 (pt)
JP (1) JP5608221B2 (pt)
KR (1) KR20120014005A (pt)
CN (1) CN102414185B (pt)
AR (1) AR076478A1 (pt)
AU (1) AU2010243362B2 (pt)
BR (1) BRPI1014627A2 (pt)
CA (1) CA2760384A1 (pt)
HU (1) HUP0900267A2 (pt)
IL (1) IL216017A0 (pt)
IN (1) IN2011KN04192A (pt)
MX (1) MX2011011530A (pt)
MY (1) MY152269A (pt)
RU (1) RU2523793C2 (pt)
SG (1) SG175829A1 (pt)
TW (1) TWI461413B (pt)
UY (1) UY32594A (pt)
WO (1) WO2010125414A1 (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8943551B2 (en) * 2008-08-14 2015-01-27 Microsoft Corporation Cloud-based device information storage
HUP0900267A2 (en) 2009-04-30 2011-03-28 Sanofi Aventis Process for preparing of thiazole amines and intermediates thereof
IL296683B2 (en) 2014-01-21 2023-12-01 Neurocrine Biosciences Inc Preparations for the treatment of congenital adrenal hyperplasia
US10207974B1 (en) 2017-12-05 2019-02-19 Chevron Phillips Chemical Company Lp Synthesis of gamma dicarbonyl and pyrrole compounds
CA3121920A1 (en) * 2018-12-07 2020-06-11 Neurocrine Biosciences, Inc. Crf1 receptor antagonist, pharmaceutical formulations and solid forms thereof for the treatment of congenital adrenal hyperplasia
EP4034111A1 (en) * 2019-09-27 2022-08-03 Neurocrine Biosciences, Inc. Crf receptor antagonists and methods of use
KR20230038458A (ko) 2020-06-10 2023-03-20 뉴로크린 바이오사이언시즈 인코퍼레이티드 선천성 부신 증식증의 치료를 위한 crf1 수용체 길항제

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB823251A (en) 1955-07-02 1959-11-11 Thomae Gmbh Dr K Improvements in or relating to preparations containing benzoxathiol derivatives for the care of hair and skin
US3222248A (en) * 1961-12-12 1965-12-07 Stauffer Chemical Co Method of controlling microorganisms by means of organic thiocyanates
US3433803A (en) 1966-12-01 1969-03-18 Olin Mathieson Substituted imino-1,3-oxathiols and their preparation
HRP921128B1 (en) 1991-10-30 1998-10-31 Sandor Garaczy Novel process for the preparation of 4-methyl-5(2-chloroethyl)-thiazole and analogues thereof
JPH1036360A (ja) 1996-02-21 1998-02-10 Kuraray Co Ltd 2−クロロ−5−クロロメチル−1,3−チアゾールの製造方法
FR2796380B3 (fr) * 1999-07-15 2001-08-17 Sanofi Synthelabo Nouveaux derives d'aminothiazoles, leur preparation et les compositions pharmaceutiques les contenant
HUP0900267A2 (en) 2009-04-30 2011-03-28 Sanofi Aventis Process for preparing of thiazole amines and intermediates thereof

Also Published As

Publication number Publication date
HU0900267D0 (en) 2009-07-28
RU2011148584A (ru) 2013-06-10
AU2010243362B2 (en) 2015-07-30
CN102414185A (zh) 2012-04-11
CA2760384A1 (en) 2010-11-04
HUP0900267A2 (en) 2011-03-28
WO2010125414A1 (en) 2010-11-04
KR20120014005A (ko) 2012-02-15
EP2424848B1 (en) 2013-03-13
RU2523793C2 (ru) 2014-07-27
EP2424848A1 (en) 2012-03-07
MY152269A (en) 2014-09-15
SG175829A1 (en) 2011-12-29
UY32594A (es) 2010-11-30
AU2010243362A1 (en) 2011-11-17
JP5608221B2 (ja) 2014-10-15
TWI461413B (zh) 2014-11-21
CN102414185B (zh) 2014-02-26
IL216017A0 (en) 2012-01-31
US8314249B2 (en) 2012-11-20
WO2010125414A8 (en) 2011-04-07
IN2011KN04192A (pt) 2015-10-02
TW201105640A (en) 2011-02-16
JP2012525368A (ja) 2012-10-22
US20120083608A1 (en) 2012-04-05
MX2011011530A (es) 2011-11-18
AR076478A1 (es) 2011-06-15

Similar Documents

Publication Publication Date Title
BRPI0916609A2 (pt) Processo para a preparação de um macrociclo
BRPI1013561A8 (pt) processo para a preparação de alogliptina
BR112012014490A2 (pt) processo para a preparação substituída de 1-o-acil-2-desóxi-2-fluoro-4-tio-beta-d-arabinofuranoses
BRPI0923748A2 (pt) Método para a preparação de dióis
BRPI0911254A2 (pt) processo para a preparação de um composto
BRPI0910916A2 (pt) Processo para a produção de um dianidroaçúcar
BRPI0915572A2 (pt) processo para a fabricação de epicloroidrina
BR112014004622A2 (pt) processo para a preparação de isocianatos
BRPI1014812A2 (pt) Processo para a produção de alacoóis
BRPI1010933A2 (pt) processo para a preparação de um pó, e, composto
BR112013010075A2 (pt) compostos intermediários e processo para a preparação de fingolimod
BRPI0914674A2 (pt) processo para preparação de um pó
BR112013008883A2 (pt) processo para a fabricação de di-hidropteridinonas
BRPI1014627A2 (pt) Processo para a preparação de [4-(2-cloro-4-metóxi-5-metilfenil)-5-metil-tiazolo-2-il]-[ 2-ciclopropil-1-(3-flúor-4-metilfenil)-etil]-amina
BRPI0817747A2 (pt) Processo para a preparação de derivados de ácido 2-di-halogenoacil-3-amino-acrílico
BR112012001731A2 (pt) Processo para a preparação de 1-benzil-3-hidroximetil-1h-indazol
BRPI0821837A2 (pt) Processo para a preparação de 6-substituídas-1-(2h)-isoquinolinonas
BRPI0914792A2 (pt) processo para a preparação de polióis
BRPI0821386A2 (pt) Processo para a preparação de r-lansoprazol amorfo estável
BRPI1008557A2 (pt) processo para a preparação de 5-/6-nitrofluoresceína
BRPI0813163A2 (pt) Método para a produção de polissiloxanos cíclicos
BRPI1010841A2 (pt) método para a fabricação de fluoroalquilnitrilas
BRPI0912512A2 (pt) Processo para a preparação de compostos
BR112012003775A2 (pt) processo para a preparação de um composto, composto e composição
BRPI1007151A2 (pt) processo, e, uso de um composto

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]